✨ Unlock Unlimited Data Exports & Disclosures Access with Tracenable Pro. Learn More →

Intra-Cellular Therapies Inc

Common Name
Intra-Cellular Therapies
Country
United States
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
860
Ticker
ITCI
Exchange
NASDAQ/NGS
Description
Intra-Cellular Therapies Inc. is a biopharmaceutical company that innovates in the development of novel drugs for treating complex psychiatric and neurological disorders. Its primary focus is on treat...

Disclosures of Intra-Cellular Therapies

Explore Intra-Cellular Therapies's complete collection of publicly available corporate disclosures, including annual reports, sustainability reports, financial statements, ESG data spreadsheets, and related web publications. Each document is sourced directly from Intra-Cellular Therapies's official channels and fully traceable to its official company sources.

The table below lists all of Intra-Cellular Therapies's' corporate disclosure by name and reporting period, ensuring full transparency and easy access.

If you want to search across Intra-Cellular Therapies's' disclosures for specific data or insights, use our Disclosure Search.

NameReporting Period
10-K
2024
10-K
2024
10-K
2023
Sustainability Report
2023
10-K
2022
10-K
2021
10-K
2020
10-K
2019
10-K
2018
10-K
2017
10-K
2016
10-K
2015
10-K
2014
10-K
2013
10-K
2013
Real-Time Disclosures Datafeed

Get Notified Within Seconds of New Corporate Disclosures

Tracenable is building a high-speed disclosure monitoring system that delivers instant alerts when companies publish new reports or data. Could a real-time datafeed (via SFTP, RSS or API) enhance your investment or analytical workflows?